Cabozantinib cancer drug molecule. Inhibitor of c-Met and VEGFR2 tyrosine kinases, used in treatment of medullary thyroid cancer
Cabozantinib cancer drug molecule. Inhibitor of c-Met and VEGFR2 tyrosine kinases, used in treatment of medullary thyroid cancer. Atoms are represented as spheres with conventional color coding: hydrogen (white), carbon (grey), oxygen (red), nitrogen (blue), fluorine (light green).
Size: 8000px × 5086px
Photo credit: © molekuul.be / Alamy / Afripics
License: Royalty Free
Model Released: None
Keywords: -met, angiogenesis, anticancer, antitumoral, atomic, atoms, cabozantanib, cabozantinib, cancer, carbon, chemical, chemistry, composition, disease, drug, fluorine, generic, hydrogen, inhibitor, kinase, medicinal, medicine, medullary, metastasis, model, molecular, molecule, nitrogen, oncologist, oncology, orphan, oxygen, pharma, pharmaceutical, pharmacology, pharmacy, product, therapy, thyroid, treatment, tumor, tyrosine, vegfr2
